Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-12-30
pubmed:abstractText
We compared radiotherapy (RT) delivery and locoregional control in patients with node-positive breast cancer randomly assigned on Cancer and Leukemia Group B 9344 to receive adjuvant doxorubicin/cyclophosphamide (AC) with patients assigned to receive AC followed by paclitaxel (AC+T).
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
30-40
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15545661-Aged, pubmed-meshheading:15545661-Antineoplastic Agents, Phytogenic, pubmed-meshheading:15545661-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15545661-Breast Neoplasms, pubmed-meshheading:15545661-Chemotherapy, Adjuvant, pubmed-meshheading:15545661-Combined Modality Therapy, pubmed-meshheading:15545661-Cyclophosphamide, pubmed-meshheading:15545661-Doxorubicin, pubmed-meshheading:15545661-Female, pubmed-meshheading:15545661-Humans, pubmed-meshheading:15545661-Mastectomy, pubmed-meshheading:15545661-Mastectomy, Segmental, pubmed-meshheading:15545661-Middle Aged, pubmed-meshheading:15545661-Neoplasm Recurrence, Local, pubmed-meshheading:15545661-Paclitaxel, pubmed-meshheading:15545661-Radiotherapy, pubmed-meshheading:15545661-Retrospective Studies, pubmed-meshheading:15545661-Surgical Procedures, Elective
pubmed:year
2005
pubmed:articleTitle
Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344.
pubmed:affiliation
Dept of Radiation Oncology, University of North Carolina School of Medicine, CB7512, Chapel Hill, NC 27599, USA. csartor@med.unc.edu
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial